Synergistic antitumor effect of chemotactic-prostate tumor-associated antigen gene-modified tumor cell vaccine and anti-CTLA-4 mAb in murine tumor model

MLA

Li, Ning, et al. “Synergistic Antitumor Effect of Chemotactic-Prostate Tumor-Associated Antigen Gene-Modified Tumor Cell Vaccine and Anti-CTLA-4 MAb in Murine Tumor Model.” Immunology Letters, vol. 113, no. 2, Nov. 2007, pp. 90–98. EBSCOhost, https://doi.org/10.1016/j.imlet.2007.07.019.

APA

Li, N., Qin, H., Li, X., Zhou, C., Wang, D., Ma, W., Lin, C., Zhang, Y., Wang, S., & Zhang, S. (2007). Synergistic antitumor effect of chemotactic-prostate tumor-associated antigen gene-modified tumor cell vaccine and anti-CTLA-4 mAb in murine tumor model. Immunology Letters, 113(2), 90–98. https://doi.org/10.1016/j.imlet.2007.07.019

Chicago

Li, Ning, Hanjun Qin, Xiaozhu Li, Chunxia Zhou, Dongmei Wang, Wenbo Ma, Chen Lin, Youhui Zhang, Shengdian Wang, and Shuren Zhang. 2007. “Synergistic Antitumor Effect of Chemotactic-Prostate Tumor-Associated Antigen Gene-Modified Tumor Cell Vaccine and Anti-CTLA-4 MAb in Murine Tumor Model.” Immunology Letters 113 (2): 90–98. doi:10.1016/j.imlet.2007.07.019.